FANCM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.527430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.233200E-01
Normal-vs-Stage2
1.666610E-01
Normal-vs-Stage3
1.293810E-01
Normal-vs-Stage4
6.039000E-01
Stage1-vs-Stage2
4.388400E-01
Stage1-vs-Stage3
1.131410E-01
Stage1-vs-Stage4
9.356800E-01
Stage2-vs-Stage3
1.126210E-01
Stage2-vs-Stage4
5.985600E-01
Stage3-vs-Stage4
8.619600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.839960E-01
Normal-vs-AfricanAmerican
1.949160E-01
Normal-vs-Asian
2.931000E-01
Caucasian-vs-AfricanAmerican
3.843400E-01
Caucasian-vs-Asian
3.296300E-02
AfricanAmerican-vs-Asian
3.952000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.547800E-01
Normal-vs-Female
2.983400E-01
Male-vs-Female
1.526200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.449800E-01
Normal-vs-Age(41-60Yrs)
1.995650E-01
Normal-vs-Age(61-80Yrs)
1.571160E-01
Normal-vs-Age(81-100Yrs)
2.609800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.384600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.354400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.585600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.172400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.110800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.039200E-01
Normal-vs-Daily Drinker
3.829400E-01
Normal-vs-Weekly Drinker
2.170800E-01
Normal-vs-Occasional Drinker
1.660010E-01
Normal-vs-Social Drinker
6.104600E-01
Non Drinker-vs-Daily Drinker
7.792400E-01
Non Drinker-vs-Weekly Drinker
7.164800E-01
Non Drinker-vs-Occasional Drinker
4.031000E-01
Non Drinker-vs-Social Drinker
9.087800E-02
Daily Drinker-vs-Weekly Drinker
5.753600E-01
Daily Drinker-vs-Occasional Drinker
2.810000E-01
Daily Drinker-vs-Social Drinker
6.674100E-02
Weekly Drinker-vs-Occasional Drinker
7.687800E-01
Weekly Drinker-vs-Social Drinker
2.340200E-01
Occasional Drinker-vs-Social Drinker
2.477200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.616400E-01
Normal-vs-Grade 2
9.167400E-01
Normal-vs-Grade 3
6.186000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.754800E-01
Grade 1-vs-Grade 3
3.469800E-01
Grade 1-vs-Grade 4
8.616400E-01
Grade 2-vs-Grade 3
2.917600E-01
Grade 2-vs-Grade 4
9.167400E-01
Grade 3-vs-Grade 4
6.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.462400E-01
Normal-vs-NonDiabetic
4.425400E-01
Diabetic-vs-NonDiabetic
9.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.107000E-01
Normal-vs-NoPancreatitis
4.539800E-01
Pancreatitis-vs-NoPancreatitis
1.246190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.337800E-01
Normal-vs-N1
1.445040E-01
N0-vs-N1
8.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.523600E-01
Normal-vs-TP53-NonMutant
4.386800E-01
TP53-Mutant-vs-TP53-NonMutant
9.334200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
